Literature DB >> 10771015

Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine receptors by choline.

R Zwart1, H P Vijverberg.   

Abstract

The effects of choline on alpha4beta4 nicotinic acetylcholine receptors, expressed in Xenopus oocytes, were investigated using in the two-microelectrode voltage clamp technique. Particular attention was paid to the interaction between the effects of acetylcholine and choline. Choline was a low-affinity agonist of alpha4beta4 receptors with an efficacy of 10% as compared to acetylcholine. Responses evoked by 1 microM acetylcholine were potentiated by low concentrations of choline and inhibited by > 10mM choline, resulting in a bell-shaped concentration-effect relationship. Conversely, the effects of choline on responses evoked by 300 microM acetylcholine resulted in a monophasic inhibition curve with an IC(50) of 0.87 mM. The data were fitted by a two-site receptor occupation model, which accounts for similar effects of various cholinergic ligands on heteromeric nicotinic receptors. The results indicate that the potentiation was a competitive effect, whereas the inhibition was due to a mixture of competitive and non-competitive effects. It is concluded that choline acts as a potent, endogenous co-agonist at heteromeric alpha4beta4 nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771015     DOI: 10.1016/s0014-2999(00)00002-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification.

Authors:  M V Guseva; D M Hopkins; J R Pauly
Journal:  Pharmacol Biochem Behav       Date:  2006-06-06       Impact factor: 3.533

2.  Activation of heteroliganded mouse muscle nicotinic receptors.

Authors:  Gustav Akk; Lorin S Milescu; Manfred Heckmann
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

3.  Effects of α7 Nicotinic Receptor Activation on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Denise F Happ; R Andrew Tasker
Journal:  Neurotox Res       Date:  2017-12-22       Impact factor: 3.911

4.  Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Sergio Alonso Y Gregorio; Angel Tabernero; J Michael McIntosh; Almudena Albillos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Activation and modulation of human α4β2 nicotinic acetylcholine receptors by the neonicotinoids clothianidin and imidacloprid.

Authors:  Ping Li; Jason Ann; Gustav Akk
Journal:  J Neurosci Res       Date:  2011-04-28       Impact factor: 4.164

6.  Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.

Authors:  Julian R A Wooltorton; Volodymyr I Pidoplichko; Ron S Broide; John A Dani
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  Interactions of atropine with heterologously expressed and native alpha 3 subunit-containing nicotinic acetylcholine receptors.

Authors:  Julie C Parker; Deboshree Sarkar; Michael W Quick; Robin A J Lester
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.

Authors:  Tse-Yu Wu; Caleb M Smith; Steven M Sine; Mark M Levandoski
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

9.  Heterogeneity of nicotinic acetylcholine receptor expression in the caudal nucleus of the solitary tract.

Authors:  David V Smith; Victor V Uteshev
Journal:  Neuropharmacology       Date:  2007-11-05       Impact factor: 5.250

10.  Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology.

Authors:  Hiroshi Tsuneki; Ramiro Salas; John A Dani
Journal:  J Physiol       Date:  2002-12-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.